Proposed S.B. No. 641
Session Year 2021
 


AN ACT REQUIRING MANUFACTURERS OF BRAND-NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.

Introduced by:
Sen. Martin M. Looney, 11th Dist.

 New today  2-4 days old  5 days & older
   Text of Bill
 Proposed Bill  [doc]
  View or Add Notes to SB-641

Add Notes to SB-641

Go To My Bills


This bill is in My Bills.
Do you wish to go to My Bills?

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 1/28/2021Referred to Joint Committee on General Law

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.